011000.KS
GeneOne Life Science, Inc.
KSC · Healthcare · Biotechnology · KR
KRW 2,670.00
+400.00%Year over year
Reported trailing growth
- Revenue
- -51.6%
- EBITDA
- +7.0%
- EBIT
- +12.9%
- EPS
- —
- Free cash flow
- +3.4%
- Operating cash flow
- -20.5%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -21.1%
- EBITDA
- +0.1%
- EBIT
- +1.4%
- Net income
- +1.8%
- EPS
- +8.3%
- Free cash flow
- +14.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026